Real-life clinical practice of onabotulinum toxin A intravesical injections for overactive bladder wet: an Italian consensus statement.

about

Real-life clinical practice of onabotulinum toxin A intravesical injections for overactive bladder wet: an Italian consensus statement.

Item

http://www.wikidata.org/entity/Q38845396

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Real-life clinical practice of ...... n Italian consensus statement.

@en

type

Item

label

Real-life clinical practice of ...... n Italian consensus statement.

@en

prefLabel

Real-life clinical practice of ...... n Italian consensus statement.

@en

P1476

Real-life clinical practice of ...... an Italian consensus statement

@en

P2093

Andrea Tubaro

http://www.w3.org/2001/XMLSchema#string

Antonella Giannantoni

http://www.w3.org/2001/XMLSchema#string

Enrico Finazzi Agrò

http://www.w3.org/2001/XMLSchema#string

Gianfranco Giocoli Nacci

http://www.w3.org/2001/XMLSchema#string

Giulio Del Popolo

http://www.w3.org/2001/XMLSchema#string

Mauro Cervigni

http://www.w3.org/2001/XMLSchema#string

Michele Spinelli

http://www.w3.org/2001/XMLSchema#string

Roberto Carone

http://www.w3.org/2001/XMLSchema#string

Stefano Salvatore

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment

Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence.

Refractory idiopathic urge urinary incontinence and botulinum A injection.

Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report.

Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder.

EAU guidelines on assessment and nonsurgical management of urinary incontinence.

Long-term adherence to antimuscarinic therapy in everyday practice: a systematic review.

An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders.

Technical aspects of botulinum toxin type A injection in the bladder to treat urinary incontinence: reviewing the procedure.

OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo-controlled, randomized, dose-ranging trial.

P2888

s00345-016-1847-x

P304

299-306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00345-016-1847-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giovanni Palleschi

Antonio Carbone

P577

2016-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1021322988

http://www.w3.org/2001/XMLSchema#string

P698

27229889

http://www.w3.org/2001/XMLSchema#string